A detailed history of Willis Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 187,795 shares of MRK stock, worth $19.1 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
187,795
Previous 187,645 0.08%
Holding current value
$19.1 Million
Previous $23.2 Million 8.2%
% of portfolio
1.43%
Previous 1.64%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$111.15 - $128.97 $16,672 - $19,345
150 Added 0.08%
187,795 $21.3 Million
Q2 2024

Jul 24, 2024

SELL
$123.8 - $132.96 $5.37 Million - $5.77 Million
-43,400 Reduced 18.78%
187,645 $23.2 Million
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $70,126 - $76,314
-700 Reduced 0.3%
231,045 $25.2 Million
Q3 2023

Mar 07, 2024

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 0.04%
231,745 $23.9 Million
Q3 2023

Oct 17, 2023

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 0.04%
231,745 $23.9 Million
Q2 2023

Mar 07, 2024

SELL
$108.61 - $118.38 $26,066 - $28,411
-240 Reduced 0.1%
231,645 $26.7 Million
Q2 2023

Jul 11, 2023

SELL
$108.61 - $118.38 $26,066 - $28,411
-240 Reduced 0.1%
231,645 $26.7 Million
Q1 2023

Mar 07, 2024

BUY
$102.94 - $114.86 $86,469 - $96,482
840 Added 0.36%
231,885 $24.7 Million
Q1 2023

Apr 18, 2023

BUY
$102.94 - $114.86 $1.87 Million - $2.09 Million
18,204 Added 8.52%
231,885 $24.7 Million
Q4 2022

Jan 18, 2023

SELL
$87.44 - $112.11 $3.9 Million - $5 Million
-44,637 Reduced 17.28%
213,681 $0
Q3 2022

Oct 12, 2022

SELL
$84.53 - $94.96 $3.11 Million - $3.49 Million
-36,755 Reduced 12.46%
258,318 $22.2 Million
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $4.45 Million - $5.04 Million
-53,300 Reduced 15.3%
295,073 $26.9 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $492,517 - $552,080
-6,700 Reduced 1.89%
348,373 $28.6 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $1.07 Million - $1.34 Million
14,773 Added 4.34%
355,073 $27.2 Million
Q3 2021

Nov 17, 2021

SELL
$71.68 - $78.83 $410,654 - $451,617
-5,729 Reduced 1.66%
340,300 $25.6 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $293,966 - $325,156
-4,181 Reduced 1.19%
346,029 $26.9 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $21,002 - $24,738
-305 Reduced 0.09%
350,210 $27 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $5.28 Million - $5.86 Million
73,600 Added 26.58%
350,515 $28.7 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $2.69 Million - $3.04 Million
-36,700 Reduced 11.7%
276,915 $23 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $22.5 Million - $25.5 Million
-318,815 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $106,381 - $147,449
-1,679 Reduced 0.52%
318,815 $24.5 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $467,109 - $527,078
-6,021 Reduced 1.84%
320,494 $29.1 Million
Q3 2019

Nov 15, 2019

SELL
$76.08 - $82.93 $2,206 - $2,404
-29 Reduced 0.01%
326,515 $27.5 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $4.78 Million - $5.58 Million
68,414 Added 26.5%
326,544 $27.4 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $4.34 Million - $4.95 Million
-62,370 Reduced 19.46%
258,130 $30.4 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $639,352 - $741,957
-9,800 Reduced 2.97%
320,500 $24.5 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $1.93 Million - $2.27 Million
-33,500 Reduced 9.21%
330,300 $23.4 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $3.54 Million - $4.16 Million
-69,700 Reduced 16.08%
363,800 $22.1 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $4.34 Million - $5.05 Million
85,213 Added 24.47%
433,500 $23.6 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $598,120 - $714,222
11,587 Added 3.44%
348,287 $19.6 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $19.8 Million - $21.3 Million
336,700
336,700 $21.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.